Your email has been successfully added to our mailing list.

×
0 -2.11863957907323E-06 -2.11863957907323E-06 -2.11863957907323E-06 -0.004239397797886 0.0192775015307171 0.0135571746670029 0.00105720114999758
Stock impact report

Should You Throw in the Towel on Intercept Pharmaceuticals After Its Big Setback? [The Motley Fool]

Intercept Pharmaceuticals, Inc. (ICPT) 
Last intercept pharmaceuticals, inc. earnings: 2/25 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.interceptpharma.com/investor-relations
Company Research Source: The Motley Fool
Intercept Pharmaceuticals(NASDAQ:ICPTThat launch won't happen anytime soon. On Monday, Intercept announced that it hadreceived a complete response letter (CRL) from the FDAImage source: Getty Images.What we know about the bad newsThe FDA doesn't release CRLs to the public, so we don't know for sure everything that was in it. However, Intercept basically stated that the agency found that the benefit of OCA doesn't outweigh the potential risks. That's a surefire recipe for an FDA rejection.But there's more to the story. Intercept's filing for OCA was for an accelerated approval, based on positive interim analysis results from the late-stage Regenerate study. With accelerated approvals, the FDA allows a surrogate endpoint to be used for faster approval.Intercept said that the FDA believes that "the predicted benefit of OCA based on a surrogate histopathologic endpoint remains uncertain." This surrogate endpoint measured the change in liver tissues caused by NASH.What about the potential Show less Read more
Impact Snapshot
Event Time:
ICPT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for ICPT alerts
Opt-in for
ICPT alerts

from News Quantified
Opt-in for
ICPT alerts

from News Quantified